Rossari Biotech Limited (NSE:ROSSARI)
| Market Cap | 27.93B -17.9% |
| Revenue (ttm) | 22.91B +16.1% |
| Net Income | 1.38B +1.2% |
| EPS | 24.85 +1.1% |
| Shares Out | 55.38M |
| PE Ratio | 20.29 |
| Forward PE | 18.11 |
| Dividend | 0.50 (0.10%) |
| Ex-Dividend Date | Jun 20, 2025 |
| Volume | 656,647 |
| Average Volume | 153,947 |
| Open | 495.00 |
| Previous Close | 478.25 |
| Day's Range | 483.10 - 507.05 |
| 52-Week Range | 375.00 - 766.00 |
| Beta | 0.33 |
| RSI | 65.75 |
| Earnings Date | Apr 27, 2026 |
About Rossari Biotech
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing li... [Read more]
Financial Performance
In fiscal year 2025, Rossari Biotech's revenue was 20.80 billion, an increase of 13.64% compared to the previous year's 18.31 billion. Earnings were 1.36 billion, an increase of 4.35%.
Financial StatementsNews
Rossari Biotech subsidiary approves Rs 10 crore sale of Mumbai office premises
Rossari Biotech's material subsidiary, Unitop Chemicals Private Limited, has approved the sale of its office premises located in Saki Naka, Mumbai. The transaction, valued at approximately ₹10 crores,...
Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ...
Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
Q3 2026 Rossari Biotech Ltd Earnings Call Transcript
Q3 2026 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Pricing Pressures
Q2 2026 Rossari Biotech Ltd Earnings Call Transcript
Q2 2026 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech’s subsidiary wins GST appeal; previous tax order set aside
Rossari Biotech Limited has announced that its subsidiary, Unitop Chemicals Private Limited, has successfully won an appeal against a GST Order issued by the Joint Commissioner, Central GST & Central ...
Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and ...
Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and Capacity Expansion Drive Performance
Q3 2025 Rossari Biotech Ltd Earnings Call Transcript
Q3 2025 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech stock drops 4.28% following Q2 results
Rossari Biotech saw its stock price fall by 4.28%, trading at ₹838.35 as of 9:35 AM today. The drop follows the company’s release of its Q2 FY24-25 earnings, which failed to meet market expectations. ...